# Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease

Study · id `cardio:ct-nct02673164` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02673164](<https://clinicaltrials.gov/study/NCT02673164>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02673164

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.

## Technical summary

Registry record NCT02673164. Randomized; quadruple masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2020-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 133 participants (enrolled count; ClinicalTrials.gov record NCT02673164, source copy `cardio:ctgov-nct02673164-2021-01-19`, retrieved 2026-10-26)
- Started: 2017-01 (actual) (ClinicalTrials.gov record NCT02673164, source copy `cardio:ctgov-nct02673164-2021-01-19`, retrieved 2026-10-26)
- Primary completion: 2020-12 (actual) (ClinicalTrials.gov record NCT02673164, source copy `cardio:ctgov-nct02673164-2021-01-19`, retrieved 2026-10-26)
- Completion: 2020-12 (actual) (ClinicalTrials.gov record NCT02673164, source copy `cardio:ctgov-nct02673164-2021-01-19`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02673164, source copy `cardio:ctgov-nct02673164-2021-01-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02673164-2021-01-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease
- Acronym: SCIENCE
- Condition: Heart Failure
- Intervention (Biological): CSCC\_ASC
- Lead sponsor: JKastrup
- Lead sponsor class: OTHER
- Collaborator: European Union
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: European Union (`cardio:org-european-union`)

## Provenance

Content hash: 44855720156899bb6d1993bf7582430ce10781d3258f564d564906ea20d1d21c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
